Utah Medical Products (UTMD) Current Assets (2010 - 2026)

Utah Medical Products' Current Assets history runs 17 years deep, the most recent figure standing at $100.4 million for Q1 2026.

• On a quarterly basis, Current Assets rose 4.13% year-over-year to $100.4 million in Q1 2026; TTM through Mar 2026 was $100.4 million, a 4.13% increase from a year earlier, with the FY2025 full-year figure at $97.7 million, up 1.47% from the prior year.
• Current Assets climbed to $100.4 million in Q1 2026 per UTMD's latest filing, from $97.7 million in the prior quarter.
• Across five years, Current Assets topped out at $107.1 million in Q1 2024 and bottomed at $79.0 million in Q2 2022.
• The 5-year median for Current Assets is $96.5 million (2025), against an average of $95.7 million.
• Across the five-year window, Current Assets gained 25.15% in 2023 and fell 10.03% in 2025, its largest moves.
• Year by year, Current Assets stood at $89.9 million in 2022, then rose by 18.18% to $106.3 million in 2023, then fell by 9.35% to $96.3 million in 2024, then rose by 1.47% to $97.7 million in 2025, then grew by 2.7% to $100.4 million in 2026.
• Per Business Quant, the three latest UTMD Current Assets figures stand at $100.4 million (Q1 2026), $97.7 million (Q4 2025), and $96.5 million (Q3 2025).